Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Renewable Energy MLP Achieves 'Clean Results from Strong Hydrology' in Q2/19

The highlights of the quarterly update are presented in an iA Securities report. In a July 31 research note, iA Securities analyst Jeremy Rosenfield reported that Brookfield Renewable Energy Partners L.P.'s (BEP.UN:TSX; BEP:NYSE) Q2/19 results were "roughly...
Streetwise Reports | August 6, 2019 |

Developer of Cannabinoid-Based Drugs to Resume Cancer Pain Trial

Calling this latest development "excellent news," Paradigm Capital has raised its target price on the company's stock. In an April 9 research note, analyst Rahul Sarugaser reported that Paradigm Capital raised its target price on Tetra Bio-Pharma Inc. (TBP:TSX.V; TBPMF...
Streetwise Reports | April 18, 2019 |

Biopharma Receives FDA Fast Track Designation for Cancer Therapeutic

An explanation of the categorization and its implications are provided in a Paradigm Capital report. In a May 30 research note, Paradigm Capital analyst Rahul Sarugaser reported that Zymeworks Inc.'s (ZYME:NYSE; ZYME:TSX) lead product candidate ZW25 wa...
Streetwise Reports | June 10, 2019 |

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Avadel Pharmaceuticals' shares traded 25% higher reaching a new 52-week high price after the company reported positive topline results from its Pivotal Phase 3 REST-ON trial of FT218 for the treatment of excessive daytime sleepiness and cataplexy in narcolepsy patients. ...
Streetwise Reports | April 28, 2020 |

Navigating Alberta's energy frontier with vision and upstream focus

The following is a transcription of the above video, and The Market Online has edited it for clarity . Fiddlehead Resources (TSXV:FHR) is a Cardium-focused energy company producing 1,750 barrels of oil equivalent per day. The company has an inventory of more than 5...
Coreena Robertson | October 10, 2024 |

Energy Firm Reacts to Oil Price Weakening with 2019 Budget Decrease

The company's revised estimates, the reasons for and repercussions of them are addressed in a CIBC report. In an Aug. 26 research note, analyst Dave Popowich reported that his firm CIBC reduced its price target on Whitecap Resources Inc. (WCP:TSX) to CA$7.25 per sha...
Streetwise Reports | September 3, 2019 |

Fed Cut Equities Stimulus 86% This Week and Stocks Are Falling

What happens to the global markets when the US Fed begins to weaken stimulus activity and when the global markets must begin to function on their own? Are the global markets capable of sustaining current price levels without the Fed supporting them? A recent news article s...
Chris Vermeulen | May 1, 2020 |

Silver Offers A Golden Opportunity To Preserve Soon To Be Destroyed Value

The fundamentals for silver and gold are very strong, and with all the massive bailouts and stimulus, which have increased debt levels, they are just getting stronger. Until a significant portion of these debts is repaid or defaulted on, it would be foolish to talk about a to...
Hubert Moolman | July 3, 2020 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

'Investors Need to Own' This Provider of Well Completion, Production Services

This energy company's growth and other prospects are discussed in a Raymond James report. In an April 12 research note, Raymond James analyst J. Marshall Adkins purported that Nine Energy Service Inc. (NINE:NYSE) is a "misunderstood stock within the oilfield sect...
Streetwise Reports | April 19, 2019 |
1 2 3 4 5 6 7 8 9 10 ...